A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma

Clinical trial NCT01522664 · COMPLETED

Trial details

NCT number: NCT01522664
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2012-03-01
Primary completion: 2015-06-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.